Price
No data yet.
Social Signal Score
Analyst Ratings
2 analystsRevenue
$54.71M-4.22%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Steven Roth
- Sector
- Real Estate
- Industry
- REIT - Retail
- Employees
- 103
- Beta
- 0.75
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 2.20
Financials
Revenue
$54.71M-4.2%Net Income
$155.36M+638.6%EBITDA
$174.39M+393.4%Free Cash Flow
$-291.0K-100.6%EPS (diluted)
$30.24+635.8%Shares Outstanding (diluted)
5.14M+0.4%Operating Expenses
$3.27MCash & Debt
$358.35MReturn of Capital
$46.22MRevenue by Segment (annual)
$9.00MDividend per Share
$4.50Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $213.18M | $28.22M | $5.50 |
| 2024 | $226.37M | $43.44M | $8.46 |
| 2023 | $224.96M | $102.41M | $19.97 |
| 2022 | $205.81M | $57.63M | $11.24 |
| 2021 | $206.15M | $132.93M | $25.94 |
| 2020 | $199.14M | $41.94M | $8.19 |
| 2019 | $226.35M | $21.17M | $4.14 |
| 2018 | $232.82M | $32.84M | $6.42 |
| 2017 | $230.57M | $80.51M | $15.74 |
| 2016 | $226.94M | $86.48M | $16.91 |
| 2015 | $207.91M | $76.91M | $15.04 |
| 2014 | $200.81M | $67.92M | $13.29 |
| 2013 | $196.46M | $56.91M | $11.14 |
| 2012 | $191.31M | $674.39M | $132.04 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ALX's reported EPS growth of -21.7% a year over 13 years. Historical EPS growth of -22% would project the company towards zero. Floored at -15% as a starting point.
- EPS in 5 years
- $2.44
- Implied price
- $97.55
- Return from $243.86
- -16.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $48.50 — -80.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 28 | 34 | 40 | 46 | 52 |
|---|---|---|---|---|---|
| -25.0% | -31.6% | -28.9% | -26.5% | -24.5% | -22.6% |
| -20.0% | -27.0% | -24.1% | -21.6% | -19.4% | -17.4% |
| -15.0% | -22.5% | -19.4% | -16.7% | -14.4% | -12.3% |
| -10.0% | -17.9% | -14.7% | -11.8% | -9.3% | -7.1% |
| -5.0% | -13.4% | -9.9% | -6.9% | -4.3% | -1.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70-58.82%Social Signal Score
Mentions (5)
- Newsglobenewswire.com·8d ago·Positive
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer Achieved 40.3% ORR with evorpacept plus trastuzumab, ramucirumab and paclitaxel versus 26.6% for control, with response rates increasing to 63.6% versus 23.1% among patients with high CD47 expression and retained HER2-positive disease
View source ↗ - Newsglobenewswire.com·34d ago·Neutral
ALX Oncology to Present at Upcoming Investor Conferences in September SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that ALX Oncology leadership will participate in fireside chats at three upcoming investor conferences.
View source ↗ - Newszacks.com·55d ago·Positive
Best Momentum Stocks to Buy for August 11th DINO, QUAD and ALX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 11, 2026.
View source ↗ - Newszacks.com·56d ago·Positive
New Strong Buy Stocks for August 11th ALX, DINO, OPBK, CYD and HLLY have been added to the Zacks Rank #1 (Strong Buy) List on August 11, 2026.
View source ↗ - Newszacks.com·56d ago·Positive
Best Income Stocks to Buy for August 11th ALX, SHIP and QUAD made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 11, 2026.
View source ↗
Earnings
Mon, Nov 2(in 4 weeks)
Consensus estimate $8.20 per share
Typical surprise +0.7% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$3.02 vs $3.00beat
- Mon, May 4$2.60 vs $3.08miss
- Mon, Feb 9$2.43 vs $3.02miss
- Mon, Nov 3$2.91 vs $2.50beat
- Mon, Aug 4$1.19 vs $3.08miss
- Mon, May 5$4.06 vs $3.57beat
Estimates and results for ALX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ALX officers and directors.
- Bought
- —
- Sold
- $2.3m
0 trades
7 trades
- Wight Russell B Jrsold
- Wight Russell B Jrsold
- Wight Russell B Jrsold
- Wight Russell B Jrsold
- Wight Russell B Jrsold
- Wight Russell B Jrsold
- Wight Russell B Jrsold
93 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ALX.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.